You should speak with a provider before considering BPC-157 if you: Have a chronic medical condition Take prescription medications Have immune system concerns Have a history of cancer Are pregnant or breastfeeding Are recovering from surgery Have ongoing pain or unexplained inflammation Are using other peptides, hormones, or performance compounds BPC-157 should not replace proper diagnosis, imaging, rehab, or medical treatment for injuries
GLP-1 medications are not generally considered controlled substances under the Ryan Haight Act, so standard controlled substance telehealth prescribing restrictions don't apply
GHK-Cu's effects on skin fibroblasts extend beyond simple matrix production
How much BAC water for a 30mg retatrutide vial
May 27, 2026 Summary: A survey finds that 35% of adults who tried GLP-1 medications stopped taking them, most commonly due to reaching their target weight, experiencing side effects, or lacking affordable coverage each posing distinct challenges for employers designing benefits
However, there are some key differences in terms of how quickly they work and their overall effectiveness